Psoralidin: emerging biological activities of therapeutic benefits and its potential utility in cervical cancer
Cervical cancer (CaCx) is the fourth most prevalent cancer in women contributing to 341,831 annual deaths globally in 2020. Owing to its high mortality rate, the identification of novel inhibitors preventing CaCx progression is of utmost importance. Recent studies have emphasized the use of phytoche...
Saved in:
Main Authors: | Tanya Tripathi, Apoorva Chaudhary, Divya Janjua, Udit Joshi, Nikita Aggarwal, Chetkar Chandra Keshavam, Alok Chandra Bharti |
---|---|
Format: | Article |
Language: | English |
Published: |
Open Exploration
2024-09-01
|
Series: | Exploration of Drug Science |
Subjects: | |
Online Access: | https://www.explorationpub.com/uploads/Article/A100863/100863.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploring covalent inhibitors of SARS-CoV-2 main protease: from peptidomimetics to novel scaffolds
by: Noor Atatreh, et al.
Published: (2025-12-01) -
Targeting EBV Episome for Anti-Cancer Therapy: Emerging Strategies and Challenges
by: Febri Gunawan Sugiokto, et al.
Published: (2025-01-01) -
Addressing Methodological and Generalizability Challenges in Cervical Rotation-Traction Manipulation (CRTM) for Cervical Radiculopathy [Letter]
by: Wang R, et al.
Published: (2025-01-01) -
Endoscopy-assisted anterior cervical discectomy and fusion with internal fixation vs conventional surgery in the treatment of cervical disc herniation
by: Haicun Zhang, et al.
Published: (2024-07-01) -
Features of the course and treatment of low back pain in patients with reduced bone mineral density
by: N. M. Shuba, et al.
Published: (2020-09-01)